PETRI DISH PERSPECTIVES
PETRI DISH PERSPECTIVES
Manead Khin
Episode 34: Astellas
25 minutes Posted Dec 18, 2025 at 4:00 pm.
Founding Story
Prograf and Transformation of Transplantation
Urology & Blockbusters
Xtandi and Major Success
Strategic Evolution
People Who Made Their Mark
What’s Next for Astellas?
Lessons from Astellas
0:00
25:30
Download MP3
Show notes
Send us Fan Mail In this episode, we explore the evolution of Astellas Pharma, from the merger of two century-old Japanese firms into a global biopharmaceutical powerhouse. We trace how a culture of disciplined research led to breakthrough medicines like Prograf, transformed transplant medicine, and later to Xtandi, a prostate cancer therapy born from academic insight and refined through global collaboration. We unpack how Astellas quietly repositioned itself toward oncology, gene therapy, an...